Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 34, Issue 1, Pages 3-78
Publisher
SAGE Publications
Online
2019-12-13
DOI
10.1177/0269881119889296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
- (2019) Jad Kesserwani et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
- (2019) Jari Tiihonen et al. JAMA Psychiatry
- The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study
- (2019) D. Siskind et al. PSYCHOPHARMACOLOGY
- Treatment Recommendations for Tardive Dyskinesia
- (2019) Lucia Ricciardi et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials
- (2019) Myeongju Cho et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Effects of cariprazine on hERG 1A and hERG 1A/3.1 potassium channels
- (2019) Hong Joon Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adjunctive minocycline for major mental disorders: A systematic review
- (2019) Wei Zheng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability
- (2019) Jill Clayton-Smith et al. Orphanet Journal of Rare Diseases
- Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders
- (2019) Arjen L. Sutterland et al. SCHIZOPHRENIA RESEARCH
- Depressive psychopathology in first-episode schizophrenia spectrum disorders: a systematic review, meta-analysis and meta-regression
- (2019) Sarah E. Herniman et al. PSYCHOLOGICAL MEDICINE
- Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
- (2018) G. Kadra et al. ACTA PSYCHIATRICA SCANDINAVICA
- The relationship between negative symptoms and depression in schizophrenia: a systematic review
- (2018) C. R. Krynicki et al. ACTA PSYCHIATRICA SCANDINAVICA
- Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
- (2018) B. Galling et al. ACTA PSYCHIATRICA SCANDINAVICA
- Mortality in schizophrenia: 30-year nationwide follow-up study
- (2018) A. Tanskanen et al. ACTA PSYCHIATRICA SCANDINAVICA
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
- (2018) Pontus Plavén-Sigray et al. BIOLOGICAL PSYCHIATRY
- The Assessment and Treatment of Antipsychotic-Induced Akathisia
- (2018) Tamara Pringsheim et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies
- (2018) Katharina Stegmayer et al. CNS DRUGS
- Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
- (2018) Michael W. Jann et al. CNS DRUGS
- α7 Nicotinic Acetylcholine Receptor
- (2018) Candace Jones JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)
- (2018) Belinda R Lennox et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis
- (2018) Antonella Macerollo et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The nosology of tardive syndromes
- (2018) Karen Frei et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
- (2018) Sameer Jauhar et al. MOLECULAR PSYCHIATRY
- Therapeutic effect of adjunctive N -acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
- (2018) Zahra Sepehrmanesh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
- (2018) Parita Shah et al. PSYCHIATRY RESEARCH
- QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update
- (2018) Scott R. Beach et al. PSYCHOSOMATICS
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis
- (2018) Cathy Davies et al. World Psychiatry
- Anticholinergic drugs and risk of dementia: case-control study
- (2018) Kathryn Richardson et al. BMJ-British Medical Journal
- Anticholinergic drugs and risk of dementia: case-control study
- (2018) Kathryn Richardson et al. BMJ-British Medical Journal
- Motivational Interviewing–Based Compliance/Adherence Therapy Interventions to Improve Psychiatric Symptoms of People With Severe Mental Illness: Meta-Analysis
- (2018) Choochart Wong-Anuchit et al. Journal of the American Psychiatric Nurses Association
- Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis
- (2018) C. Okhuijsen-Pfeifer et al. ACTA PSYCHIATRICA SCANDINAVICA
- Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial
- (2018) Doreen Gruber et al. Brain Stimulation
- Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
- (2018) Richard I. G. Holt et al. BRITISH JOURNAL OF PSYCHIATRY
- Association between increased serum d -serine and cognitive gains induced by intensive cognitive training in schizophrenia
- (2018) Rogerio Panizzutti et al. SCHIZOPHRENIA RESEARCH
- Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review
- (2018) Kristen N. Knoph et al. SCHIZOPHRENIA RESEARCH
- Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
- (2018) Maren Carbon et al. World Psychiatry
- Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
- (2018) Yoshie Omachi et al. Frontiers in Psychiatry
- Care of Women with Obesity in Pregnancy
- (2018) FC Denison et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births
- (2018) Shan-Yan Gao et al. BMC Medicine
- Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study
- (2018) Megan Galbally et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Long-acting injectable second-generation antipsychotics in first-episode psychosis
- (2018) Monika Salgueiro et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia
- (2018) Borja Santos et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
- (2018) Mark Weiser et al. SCHIZOPHRENIA RESEARCH
- Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia
- (2018) Sophie Hackinger et al. Translational Psychiatry
- Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status
- (2018) C. Gurvich et al. PSYCHONEUROENDOCRINOLOGY
- Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
- (2017) Ying-Qiang Xiang et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis
- (2017) Yikang Zhu et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
- (2017) Hanna Bergman et al. HEALTH TECHNOLOGY ASSESSMENT
- Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder
- (2017) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia
- (2017) Wei Zheng et al. JOURNAL OF CLINICAL PSYCHIATRY
- Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use
- (2017) Maren Carbon et al. JOURNAL OF CLINICAL PSYCHIATRY
- High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders
- (2017) Thierry Q. Mentzel et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia
- (2017) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
- (2017) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288
- (2017) Kelvin W Gee et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment
- (2017) Gavin P Reynolds et al. JOURNAL OF PSYCHOPHARMACOLOGY
- British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017
- (2017) R Hamish McAllister-Williams et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders
- (2017) David J Castle et al. MEDICAL JOURNAL OF AUSTRALIA
- Cognition and the course of prodromal Parkinson's disease
- (2017) Daniel Weintraub et al. MOVEMENT DISORDERS
- Randomized controlled trial of deutetrabenazine for tardive dyskinesia
- (2017) Hubert H. Fernandez et al. NEUROLOGY
- Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation
- (2017) William R Kem et al. NEUROPSYCHOPHARMACOLOGY
- Violence to Others, Violent Self-Victimization, and Violent Victimization by Others Among Persons With a Mental Illness
- (2017) John Monahan et al. PSYCHIATRIC SERVICES
- The critical treatment window of clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study
- (2017) Bunta Yoshimura et al. PSYCHIATRY RESEARCH
- Stability and development of psychotic symptoms and the use of antipsychotic medication – long-term follow-up
- (2017) D. R. Gotfredsen et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
- (2017) A. Demjaha et al. PSYCHOLOGICAL MEDICINE
- Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
- (2017) W. Zheng et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis
- (2017) J. Vermeulen et al. PSYCHOLOGICAL MEDICINE
- Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis
- (2017) Taro Kishi et al. PSYCHOPHARMACOLOGY
- Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
- (2017) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- 112. Effects of Ziprasidone Versus Placebo in Patients at Clinical High Risk for Psychosis
- (2017) Scott Woods et al. SCHIZOPHRENIA BULLETIN
- Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
- (2017) Taishiro Kishimoto et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Combinations for Schizophrenia
- (2017) Javier Ortiz-Orendain et al. SCHIZOPHRENIA BULLETIN
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- 108. PREVENT: A Randomized Controlled Trial for the Prevention of First-Episode Psychosis Comparing Cognitive–Behavior Therapy (CBT), Clinical Management, and Aripiprazole Combined and Clinical Management and Placebo Combined
- (2017) Andreas Bechdolf et al. SCHIZOPHRENIA BULLETIN
- 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium
- (2017) Kristin Cadenhead et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
- (2017) Britta Galling et al. World Psychiatry
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study
- (2017) Hanna M. Heller et al. BMC Pregnancy and Childbirth
- Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis
- (2017) Areti Angeliki Veroniki et al. BMJ Open
- Statin prescribing for people with severe mental illnesses: a staggered cohort study of ‘real-world’ impacts
- (2017) R Blackburn et al. BMJ Open
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- Impaired Glucose Homeostasis in First-Episode Schizophrenia
- (2017) Toby Pillinger et al. JAMA Psychiatry
- Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
- (2017) Patrick D. McGorry et al. JAMA Psychiatry
- Capturing Rest-Activity Profiles in Schizophrenia using Wearable and Mobile Technologies: Development, Implementation, Feasibility and Acceptability of a Remote Monitoring Platform. (Preprint)
- (2017) Nicholas Meyer et al. JMIR mHealth and uHealth
- Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
- (2017) Thomas W. Weickert et al. Frontiers in Psychiatry
- Effect of Olanzapine and Risperidone on Subjective Well-Being and Craving for Cannabis in Patients with Schizophrenia or Related Disorders: A Double-Blind Randomized Controlled Trial
- (2017) Lonneke J van Nimwegen et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Early Predictors of Nonadherence to Antipsychotic Therapy in First-Episode Psychosis
- (2017) Mark Rabinovitch et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- The Epidemiology of Excess Mortality in People with Mental Illness
- (2017) David Lawrence et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Depression during first episode psychosis and subsequent suicide risk: A systematic review and meta-analysis of longitudinal studies
- (2017) Jessica McGinty et al. SCHIZOPHRENIA RESEARCH
- Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort study
- (2017) Leo Malandain et al. SCHIZOPHRENIA RESEARCH
- Sodium valproate and clozapine induced neutropenia: A case control study using register data
- (2017) Steffi Malik et al. SCHIZOPHRENIA RESEARCH
- Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
- (2017) Heidi Taipale et al. SCHIZOPHRENIA RESEARCH
- Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practice
- (2017) Emily Eisner et al. SCHIZOPHRENIA RESEARCH
- Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS®): A six-month post-discharge prospective study
- (2017) David Misdrahi et al. SCHIZOPHRENIA RESEARCH
- Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis
- (2016) Emmert Roberts et al. ADDICTION
- Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis
- (2016) Qi Wu et al. ADDICTION
- Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
- (2016) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis
- (2016) Bartosz Helfer et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
- (2016) George M. Haig et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neuroleptic Malignant Syndrome
- (2016) Dominic J. Pileggi et al. ANNALS OF PHARMACOTHERAPY
- Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis
- (2016) Richard Gray et al. BMC Psychiatry
- Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies
- (2016) Zi-Qi Shen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
- (2016) Dan Siskind et al. BRITISH JOURNAL OF PSYCHIATRY
- Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature
- (2016) William M. Greenberg et al. CLINICAL PHARMACOKINETICS
- Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
- (2016) M. Alvarez-Jimenez et al. CNS DRUGS
- Worldwide Differences in Regulations of Clozapine Use
- (2016) Jimmi Nielsen et al. CNS DRUGS
- Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
- (2016) Eduard Parellada et al. CNS DRUGS
- Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital
- (2016) Keir Stone-Brown et al. CNS SPECTRUMS
- D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
- (2016) Donald Goff Current Neuropharmacology
- Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
- (2016) John Yin et al. Current Neuropharmacology
- Antipsychotic Management of Schizoaffective Disorder: A Review
- (2016) Jean-Pierre Lindenmayer et al. DRUGS
- Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review
- (2016) Marc De Hert et al. Expert Opinion On Drug Safety
- Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records
- (2016) Irene Petersen et al. HEALTH TECHNOLOGY ASSESSMENT
- Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
- (2016) Thomas RE Barnes et al. HEALTH TECHNOLOGY ASSESSMENT
- Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
- (2016) Larry Alphs et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Antipsychotic polypharmacy and quality of life in patients with schizophrenia treated in primary care in China
- (2016) Cai-Lan Hou et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti-Infective Agents: A Systematic Literature Review From the ARITMO Project
- (2016) Lorna Hazell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Sudden-Onset Catatonia Following Clozapine Withdrawal
- (2016) Ivan Koychev et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia
- (2016) Chen Zhang et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
- (2016) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Second-Generation Antipsychotics During the Lactation Period
- (2016) Faruk Uguz JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives
- (2016) Jaya L. Padmanabhan et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders
- (2016) Joseph V Thompson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up
- (2016) Hiroshi Kimura et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology
- (2016) David J Nutt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
- (2016) GM Goodwin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
- (2016) Stephen J Cooper et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
- (2016) Robert M Anthenelli et al. LANCET
- Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia
- (2016) Ping-Tao Tseng et al. MEDICINE
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms and Future Directions
- (2016) Brian J Miller et al. NEUROPSYCHOPHARMACOLOGY
- Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy
- (2016) Gillian E. Hanley et al. OBSTETRICS AND GYNECOLOGY
- Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial
- (2016) Robert C. Smith et al. PLoS One
- Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trial
- (2016) Deanna M. Barch et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Long-acting injectable antipsychotics for the prevention of relapse in patients with recent-onset psychotic disorders: A systematic review and meta-analysis of randomized controlled trials
- (2016) Taro Kishi et al. PSYCHIATRY RESEARCH
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
- (2016) Andreas Schreiner et al. PSYCHOPHARMACOLOGY
- Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy
- (2016) Savita G. Bhakta et al. PSYCHOPHARMACOLOGY
- A Meta-analytic Review of Auditory Event-Related Potential Components as Endophenotypes for Schizophrenia: Perspectives From First-Degree Relatives
- (2016) Holly A. Earls et al. SCHIZOPHRENIA BULLETIN
- Bipolar At-Risk Criteria: An Examination of Which Clinical Features Have Optimal Utility for Identifying Youth at Risk of Early Transition From Depression to Bipolar Disorders
- (2016) Jan Scott et al. SCHIZOPHRENIA BULLETIN
- Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
- (2016) Sophie E. Legge et al. SCHIZOPHRENIA RESEARCH
- Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis
- (2016) Rebekah Carney et al. SCHIZOPHRENIA RESEARCH
- Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
- (2016) Giouliana Kadra et al. SCHIZOPHRENIA RESEARCH
- Declining transition rates to psychotic disorder in “ultra-high risk” clients: Investigation of a dilution effect
- (2016) Jessica A. Hartmann et al. SCHIZOPHRENIA RESEARCH
- The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
- (2016) Helene Speyer et al. World Psychiatry
- Risk factors for QTc-prolongation: systematic review of the evidence
- (2016) Eline Vandael et al. International Journal of Clinical Pharmacy
- Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
- (2016) Stefan Priebe et al. BMJ Open
- Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women
- (2016) Jayashri Kulkarni et al. JAMA Psychiatry
- Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
- (2016) Myrto T. Samara et al. JAMA Psychiatry
- Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations
- (2016) Krista F. Huybrechts et al. JAMA Psychiatry
- Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study
- (2016) Yongmin Kim et al. Clinical Psychopharmacology and Neuroscience
- Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
- (2015) M. De Hert et al. ACTA PSYCHIATRICA SCANDINAVICA
- Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials
- (2015) R. E. Nielsen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review
- (2015) Myrto T. Samara et al. AMERICAN JOURNAL OF PSYCHIATRY
- Outcomes of Nontransitioned Cases in a Sample at Ultra-High Risk for Psychosis
- (2015) Ashleigh Lin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pregnancy Exposure to Olanzapine, Quetiapine, Risperidone, Aripiprazole and Risk of Congenital Malformations. A Systematic Review
- (2015) Zandra Nymand Ennis et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses
- (2015) Clare L Taylor et al. BMC Psychiatry
- Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase
- (2015) Lucia R. Valmaggia et al. BRITISH JOURNAL OF PSYCHIATRY
- Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review
- (2015) Denise Froes Brandao et al. CANCER
- Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies
- (2015) F Salvo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
- (2015) Corinne Beinat et al. CNS DRUGS
- The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
- (2015) Marc De Hert et al. CNS DRUGS
- Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
- (2015) Lurdes Tse et al. Current Neuropharmacology
- Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study
- (2015) Benjamin Sneider et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- (2015) Pál Czobor et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors
- (2015) Rosa Ayesa-Arriola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics
- (2015) Erica A. Voss et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
- (2015) Xinyu Zhou et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn
- (2015) Krista F. Huybrechts et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals
- (2015) Jacqueline Mayoral-van Son et al. JOURNAL OF CLINICAL PSYCHIATRY
- Optimizing Outcomes in Clozapine Rechallenge Following Neutropenia
- (2015) Nicholas Meyer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment
- (2015) Frederik Vandenberghe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia
- (2015) Somaia Mohamed et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms
- (2015) Robert McCutcheon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
- (2015) Anthony Cleare et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
- (2015) T W Weickert et al. MOLECULAR PSYCHIATRY
- Parkinsonism following neuroleptic exposure: A double-hit hypothesis?
- (2015) Roberto Erro et al. MOVEMENT DISORDERS
- Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
- (2015) Richard SE Keefe et al. NEUROPSYCHOPHARMACOLOGY
- Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis
- (2015) Neal R Swerdlow et al. NEUROPSYCHOPHARMACOLOGY
- A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
- (2015) Kyra-Verena Sendt et al. PSYCHIATRY RESEARCH
- Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
- (2015) P. Gardner-Sood et al. PSYCHOLOGICAL MEDICINE
- Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation
- (2015) Randal G. Ross et al. SCHIZOPHRENIA BULLETIN
- Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms
- (2015) Sonia Dollfus et al. SCHIZOPHRENIA BULLETIN
- Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention
- (2015) Richard J. Drake et al. SCHIZOPHRENIA BULLETIN
- Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
- (2015) David Walling et al. SCHIZOPHRENIA BULLETIN
- Magnetic Resonance Imaging and the Prediction of Outcome in First-Episode Schizophrenia: A Review of Current Evidence and Directions for Future Research
- (2015) P. Dazzan et al. SCHIZOPHRENIA BULLETIN
- Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders
- (2015) Suraj Sarvode Mothi et al. SCHIZOPHRENIA RESEARCH
- Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
- (2015) Markus Dold et al. SCHIZOPHRENIA RESEARCH
- Glasgow Antipsychotic Side-effects Scale for Clozapine — Development and validation of a clozapine-specific side-effects scale
- (2015) Caroline Hynes et al. SCHIZOPHRENIA RESEARCH
- Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
- (2015) Lawrence H. Yang et al. SCHIZOPHRENIA RESEARCH
- Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia
- (2015) Andreas Schreiner et al. SCHIZOPHRENIA RESEARCH
- Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review
- (2015) Sophie M. Heringa et al. SCHIZOPHRENIA RESEARCH
- Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
- (2015) Nanna Gilliam Toftdahl et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
- (2015) Martino Belvederi Murri et al. Drugs in research & development
- Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
- (2015) G. Paul Amminger et al. Nature Communications
- Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study
- (2015) Naoki Hashimoto et al. Annals of General Psychiatry
- Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK
- (2015) T R E Barnes et al. BMJ Open
- Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
- (2015) K. H. Thomas et al. BMJ-British Medical Journal
- Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study
- (2015) S. N. Vigod et al. BMJ-British Medical Journal
- Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
- (2015) K. H. Thomas et al. BMJ-British Medical Journal
- Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study
- (2015) S. N. Vigod et al. BMJ-British Medical Journal
- Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-wide Case-Crossover Study
- (2015) C.-S. Wu et al. Journal of the American Heart Association
- Cumulative Use of Strong Anticholinergics and Incident Dementia
- (2015) Shelly L. Gray et al. JAMA Internal Medicine
- Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia
- (2015) Kenneth L. Subotnik et al. JAMA Psychiatry
- Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia
- (2015) Joris Berwaerts et al. JAMA Psychiatry
- Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study
- (2015) Lu Ban et al. PLoS One
- The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach
- (2014) K. Beck et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Comparison of the Risk of QT Prolongation Among SSRIs
- (2014) Kylee A. Funk et al. ANNALS OF PHARMACOTHERAPY
- Stimulant use disorders in people with psychosis: A meta-analysis of rate and factors affecting variation
- (2014) Grant E Sara et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Maternal and newborn outcomes among women with schizophrenia: a retrospective population-based cohort study
- (2014) SN Vigod et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection
- (2014) Susan Atkins et al. BMC Psychiatry
- Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study
- (2014) Mike J. Crawford et al. BRITISH JOURNAL OF PSYCHIATRY
- Brugada Syndrome ECG Is Highly Prevalent in Schizophrenia
- (2014) Marieke T. Blom et al. Circulation-Arrhythmia and Electrophysiology
- Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
- (2014) L Johannesen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The psychopharmacology of violence: making sensible decisions
- (2014) Leslie Citrome et al. CNS SPECTRUMS
- Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting
- (2014) Bonginkosi Chiliza et al. Early Intervention in Psychiatry
- Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
- (2014) R. Brauer et al. EUROPEAN HEART JOURNAL
- How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses
- (2014) Tiago Reis Marques et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review
- (2014) Marc De Hert et al. Expert Opinion On Drug Safety
- Structural neuroimaging in psychosis: a systematic review and economic evaluation
- (2014) E Albon et al. HEALTH TECHNOLOGY ASSESSMENT
- Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia
- (2014) Joseph P. McEvoy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder
- (2014) Dong-Jing Fu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacological Management of Persistent Hostility and Aggression in Persons With Schizophrenia Spectrum Disorders: A Systematic Review
- (2014) Jeff Victoroff et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Family-Focused Treatment for Adolescents and Young Adults at High Risk for Psychosis: Results of a Randomized Trial
- (2014) David J. Miklowitz et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Antipsychotics, mood stabilisers, and risk of violent crime
- (2014) Seena Fazel et al. LANCET
- Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
- (2014) Anthony P Morrison et al. LANCET
- Diabetes mellitus and severe mental illness: mechanisms and clinical implications
- (2014) Richard I. G. Holt et al. Nature Reviews Endocrinology
- A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
- (2014) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study
- (2014) Gunilla Ringbäck Weitoft et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
- (2014) S. Veerman et al. PHARMACOPSYCHIATRY
- Special Section on Implications of CATIE: Lessons to Take Home From CATIE
- (2014) William T. Carpenter et al. PSYCHIATRIC SERVICES
- Time to Discontinuation of Depot and Oral First-Generation Antipsychotics in the Usual Care of Schizophrenia
- (2014) Baojin Zhu et al. PSYCHIATRIC SERVICES
- Medication Preferences and Adherence Among Individuals With Severe Mental Illness and Psychiatric Advance Directives
- (2014) Christine M. Wilder et al. PSYCHIATRIC SERVICES
- Views of Young People in Early Intervention Services for First-Episode Psychosis in England
- (2014) Helen Lester et al. PSYCHIATRIC SERVICES
- Depression in first episode psychosis: The role of subordination and shame
- (2014) Rachel Upthegrove et al. PSYCHIATRY RESEARCH
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
- (2014) C. Morgan et al. PSYCHOLOGICAL MEDICINE
- Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
- (2014) S. Leucht et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Treatment and Mortality in Schizophrenia
- (2014) M. Torniainen et al. SCHIZOPHRENIA BULLETIN
- The Kraepelinian Dichotomy Viewed by Neuroimaging
- (2014) M.-A. d'Albis et al. SCHIZOPHRENIA BULLETIN
- Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
- (2014) J. Nielsen et al. SCHIZOPHRENIA BULLETIN
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Impact of early intervention services on duration of untreated psychosis: Data from the National EDEN prospective cohort study
- (2014) Max Marshall et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic Drugs and Safety Concerns for Breast-Feeding Infants
- (2014) Tapan Parikh et al. SOUTHERN MEDICAL JOURNAL
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Multimodal assessments of the hippocampal formation in schizophrenia and bipolar disorder: Evidences from neurobehavioral measures and functional and structural MRI
- (2014) Christian Knöchel et al. NeuroImage-Clinical
- Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
- (2014) Petter Andreas Ringen et al. Frontiers in Psychiatry
- Practitioner attitudes to clozapine initiation
- (2013) S. Gee et al. ACTA PSYCHIATRICA SCANDINAVICA
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study
- (2013) François R. Girardin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
- (2013) Casey Crump et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
- (2013) Ann M. Kring et al. AMERICAN JOURNAL OF PSYCHIATRY
- Statins and Cognitive Function
- (2013) Karl Richardson et al. ANNALS OF INTERNAL MEDICINE
- α7-Nicotinic Acetylcholine Receptor Agonists for Cognitive Enhancement in Schizophrenia
- (2013) Robert Freedman Annual Review of Medicine
- Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
- (2013) Deanna L Kelly et al. BMC Psychiatry
- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes
- (2013) Thomas R. E. Barnes et al. BRITISH JOURNAL OF PSYCHIATRY
- Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value
- (2013) Jan Scott et al. BRITISH JOURNAL OF PSYCHIATRY
- Cognitive function in schizophrenia: insights from intelligence research
- (2013) Eileen M. Joyce BRITISH JOURNAL OF PSYCHIATRY
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
- (2013) Jan Volavka et al. CNS SPECTRUMS
- Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital
- (2013) James E. Hotham et al. CNS SPECTRUMS
- Polypharmacy for schizophrenia
- (2013) Jacob Ballon et al. CURRENT OPINION IN PSYCHIATRY
- What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis
- (2013) Shi Mei Kam et al. Early Intervention in Psychiatry
- Antipsychotic response in first-episode schizophrenia: efficacy of high doses and switching
- (2013) Ofer Agid et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension
- (2013) Philip D. Harvey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS®) in the Swedish COAST-study
- (2013) Cecilia Brain et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: A comparison of methods for the measurement of adherence in schizophrenia
- (2013) Cecilia Brain et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
- (2013) Elena Huerta-Ramos et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Improved quality of life over one year is associated with improved adherence in patients with schizophrenia
- (2013) K.P. Hayhurst et al. EUROPEAN PSYCHIATRY
- New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
- (2013) Leslie Citrome Expert Review of Neurotherapeutics
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
- (2013) Jakob Christensen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The subjective experience and phenomenology of depression following first episode psychosis: A qualitative study using photo-elicitation
- (2013) Amrita Sandhu et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia
- (2013) Noam Y. Kirson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Termination of Clozapine Treatment Due to Medical Reasons
- (2013) Jimmi Nielsen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Atypical Antipsychotic Drugs and Pregnancy Outcome
- (2013) Frank Habermann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Inflammation and the two-hit hypothesis of schizophrenia
- (2013) Keith A. Feigenson et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Acute and subacute drug-induced movement disorders
- (2013) Pierre R. Burkhard PARKINSONISM & RELATED DISORDERS
- Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
- (2013) Xianbin Li et al. PLoS One
- Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study
- (2013) Mei Peng et al. PSYCHOPHARMACOLOGY
- Intermittent Drug Techniques for Schizophrenia
- (2013) S. Sampson et al. SCHIZOPHRENIA BULLETIN
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- The Effect of Motivational Interviewing on Medication Adherence and Hospitalization Rates in Nonadherent Patients with Multi-Episode Schizophrenia
- (2013) E. Barkhof et al. SCHIZOPHRENIA BULLETIN
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year
- (2013) Javier Sanz-Fuentenebro et al. SCHIZOPHRENIA RESEARCH
- How to compare doses of different antipsychotics: A systematic review of methods
- (2013) Maxine X. Patel et al. SCHIZOPHRENIA RESEARCH
- Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up
- (2013) Marjo Kiviniemi et al. SCHIZOPHRENIA RESEARCH
- Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12month and longer-term follow-ups
- (2013) Mark van der Gaag et al. SCHIZOPHRENIA RESEARCH
- Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades — A Danish nationwide study from 1980 to 2010
- (2013) René Ernst Nielsen et al. SCHIZOPHRENIA RESEARCH
- Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review
- (2013) Robert B. Zipursky et al. SCHIZOPHRENIA RESEARCH
- Rates and predictors of remission in first-episode schizophrenia within 1year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia
- (2013) Wolfgang Gaebel et al. SCHIZOPHRENIA RESEARCH
- Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study
- (2013) Michele Tinazzi et al. SCHIZOPHRENIA RESEARCH
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
- (2013) Goran Medic et al. Neuropsychiatric Disease and Treatment
- Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
- (2013) José M Olivares et al. Annals of General Psychiatry
- Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study
- (2013) Daniel J Smith et al. BMJ Open
- Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States
- (2013) K. Palmsten et al. BMJ-British Medical Journal
- Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial
- (2013) S. Priebe et al. BMJ-British Medical Journal
- The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
- (2013) D. Lawrence et al. BMJ-British Medical Journal
- Remission in Schizophrenia: Critical and Systematic Review
- (2013) Bandar AlAqeel et al. HARVARD REVIEW OF PSYCHIATRY
- Boundaries of Schizoaffective Disorder
- (2013) Roman Kotov et al. JAMA Psychiatry
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Pathways to Violent Behavior During First-Episode Psychosis
- (2013) Catherine Winsper et al. JAMA Psychiatry
- Comparative Mortality Risk in Adult Patients With Schizophrenia, Depression, Bipolar Disorder, Anxiety Disorders, and Attention-Deficit/Hyperactivity Disorder Participating in Psychopharmacology Clinical Trials
- (2013) Arif Khan et al. JAMA Psychiatry
- Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication
- (2013) Lori E. Ross et al. JAMA Psychiatry
- Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
- (2012) W. Victor R. Vieweg et al. AMERICAN JOURNAL OF MEDICINE
- Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
- (2012) Xiang Yang Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Polypharmacy With Antipsychotics, Antidepressants, or Benzodiazepines and Mortality in Schizophrenia
- (2012) Jari Tiihonen ARCHIVES OF GENERAL PSYCHIATRY
- Predicting Psychosis
- (2012) Paolo Fusar-Poli ARCHIVES OF GENERAL PSYCHIATRY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review
- (2012) Mark Taylor et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
- (2012) Stefan Leucht et al. BRITISH JOURNAL OF PSYCHIATRY
- Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation
- (2012) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- Venous Thromboembolism in Recipients of Antipsychotics
- (2012) Anna K. Jönsson et al. CNS DRUGS
- Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses
- (2012) Juliano S Souza et al. CNS SPECTRUMS
- Osteoporosis and fracture risk in people with schizophrenia
- (2012) Taishiro Kishimoto et al. CURRENT OPINION IN PSYCHIATRY
- Drug-Induced Parkinsonism in the Elderly
- (2012) José Luis López-Sendón et al. DRUGS & AGING
- Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged
- (2012) Lewis Couchman et al. Early Intervention in Psychiatry
- Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis
- (2012) P. Fusar-Poli et al. EUROPEAN PSYCHIATRY
- Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia
- (2012) Nancy E. Morden et al. GENERAL HOSPITAL PSYCHIATRY
- Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010
- (2012) Sally Bowskill et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
- (2012) J. J. Stephenson et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
- (2012) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
- (2012) Jian-Ping Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A systematic review of the evidence of clozapine's anti-aggressive effects
- (2012) Catherine Frogley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacotherapy challenges in patients with first-episode psychosis
- (2012) Amal Abdel-Baki et al. JOURNAL OF AFFECTIVE DISORDERS
- Drug-Induced Parkinsonism
- (2012) Hae-Won Shin et al. Journal of Clinical Neurology
- Overview of Violence to Self and Others During the First Episode of Psychosis
- (2012) Olav B. Nielssen et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis
- (2012) Patrick D. McGorry et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparison of Treatment Response in Second-Episode Versus First-Episode Schizophrenia
- (2012) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
- (2012) AR Lingford-Hughes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature
- (2012) Marcia Vervloet et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Teratogenic effects of antiepileptic drugs
- (2012) Torbjörn Tomson et al. LANCET NEUROLOGY
- Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort
- (2012) A. Foubert-Samier et al. NEUROLOGY
- Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
- (2012) Georg Winterer et al. NEUROPHARMACOLOGY
- Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study
- (2012) Deepak C D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia
- (2012) Jose Manuel Montes et al. PSYCHIATRY RESEARCH
- Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
- (2012) M. Lahti et al. PSYCHOLOGICAL MEDICINE
- Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
- (2012) P. Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- How Frequent Are Radiological Abnormalities in Patients With Psychosis? A Review of 1379 MRI Scans
- (2012) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
- (2012) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- Duration of untreated psychosis and negative symptoms — A systematic review and meta-analysis of individual patient data
- (2012) Nynke Boonstra et al. SCHIZOPHRENIA RESEARCH
- Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009
- (2012) Juan A. Gallego et al. SCHIZOPHRENIA RESEARCH
- A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
- (2012) K.N. Roy Chengappa et al. SCHIZOPHRENIA RESEARCH
- Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment
- (2012) Sefa Vayısoğlu et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial
- (2012) A. P. Morrison et al. BMJ-British Medical Journal
- The Psychosis High-Risk State
- (2012) Paolo Fusar-Poli et al. JAMA Psychiatry
- Augmentation of clozapine with a second antipsychotic - a meta-analysis
- (2011) D. M. Taylor et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder
- (2011) L. Elliot Hong ARCHIVES OF GENERAL PSYCHIATRY
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial
- (2011) Ragy R. Girgis et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic Polypharmacy in Schizophrenia
- (2011) Thomas R.E. Barnes et al. CNS DRUGS
- Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics
- (2011) Jimmi Nielsen et al. CNS DRUGS
- Pharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry Settings
- (2011) Leslie Citrome et al. CNS DRUGS
- Factors associated with adherence to treatment with olanzapine and other atypical antipsychotic medications in patients with schizophrenia
- (2011) Hong Liu-Seifert et al. COMPREHENSIVE PSYCHIATRY
- Clozapine resistance: Augmentation strategies
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis
- (2011) G. Faber et al. EUROPEAN PSYCHIATRY
- An Algorithm-Based Approach to First-Episode Schizophrenia
- (2011) Ofer Agid et al. JOURNAL OF CLINICAL PSYCHIATRY
- Sudden Deaths in Psychiatric Patients
- (2011) Peter Manu et al. JOURNAL OF CLINICAL PSYCHIATRY
- An International Consensus Study of Neuroleptic Malignant Syndrome Diagnostic Criteria Using the Delphi Method
- (2011) Ronald J. Gurrera et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predicting Dopamine D2 Receptor Occupancy From Plasma Levels of Antipsychotic Drugs
- (2011) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Suicidal Behavior and Depression in Smoking Cessation Treatments
- (2011) Thomas J. Moore et al. PLoS One
- A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
- (2011) Huafang Li et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Examining a progressive model of self-stigma and its impact on people with serious mental illness
- (2011) Patrick W. Corrigan et al. PSYCHIATRY RESEARCH
- Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes
- (2011) Serge Sevy et al. PSYCHIATRY RESEARCH
- Remission after first-episode schizophrenia: Results of a long-term follow-up
- (2011) Alp Üçok et al. PSYCHIATRY RESEARCH
- Mortality in first-contact psychosis patients in the UK: a cohort study
- (2011) R. Dutta et al. PSYCHOLOGICAL MEDICINE
- Association between public views of mental illness and self-stigma among individuals with mental illness in 14 European countries
- (2011) S. Evans-Lacko et al. PSYCHOLOGICAL MEDICINE
- Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis
- (2011) Benedicto Crespo-Facorro et al. PSYCHOPHARMACOLOGY
- Neurocognitive Predictors of Work Outcome in Recent-Onset Schizophrenia
- (2011) K. H. Nuechterlein et al. SCHIZOPHRENIA BULLETIN
- Pathways to Aggression in Schizophrenia Affect Results of Treatment
- (2011) J. Volavka et al. SCHIZOPHRENIA BULLETIN
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
- (2011) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis
- (2011) Eric Michael Hecht et al. SCHIZOPHRENIA RESEARCH
- Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia
- (2011) Jaewon Yang et al. SCHIZOPHRENIA RESEARCH
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey
- (2010) Annette K. McClave et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Reassessing the Long-term Risk of Suicide After a First Episode of Psychosis
- (2010) Rina Dutta et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
- (2010) Jason R. Tregellas et al. BIOLOGICAL PSYCHIATRY
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Twenty-five year mortality of a community cohort with schizophrenia
- (2010) Steve Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death
- (2010) C. van Noord et al. HEART
- Death by confounding: bias and mortality
- (2010) S. N. Ghaemi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention
- (2010) Wolfgang Gaebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Systematic Review of Aripiprazole—Dose, Plasma Concentration, Receptor Occupancy, and Response
- (2010) Anna Sparshatt et al. JOURNAL OF CLINICAL PSYCHIATRY
- Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis
- (2010) Alison R. Yung et al. JOURNAL OF CLINICAL PSYCHIATRY
- Paliperidone Extended-Release in Schizoaffective Disorder
- (2010) Carla M. Canuso et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales
- (2010) Kirsten Windfuhr et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Overlapping clusters of gray matter deficits in paranoid schizophrenia and psychotic bipolar mania with family history
- (2010) Liqian Cui et al. NEUROSCIENCE LETTERS
- Hyperprolactinaemia in early psychosis—not only due to antipsychotics
- (2010) Jacqueline Aston et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Self-stigma and stages of change as predictors of treatment adherence of individuals with schizophrenia
- (2010) Hector Wing-hong Tsang et al. PSYCHIATRY RESEARCH
- Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
- (2010) Diego Novick et al. PSYCHIATRY RESEARCH
- Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
- (2010) Virginia L. Stauffer et al. PSYCHIATRY RESEARCH
- The different trajectories of antipsychotic response: antipsychotics versus placebo
- (2010) T. R. Marques et al. PSYCHOLOGICAL MEDICINE
- The Brief Negative Symptom Scale: Psychometric Properties
- (2010) Brian Kirkpatrick et al. SCHIZOPHRENIA BULLETIN
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study
- (2010) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Early risk factors for suicide in an epidemiological first episode psychosis cohort
- (2010) Rina Dutta et al. SCHIZOPHRENIA RESEARCH
- Plasma Clozapine, Norclozapine, and the Clozapine:Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993–2007
- (2010) Lewis Couchman et al. THERAPEUTIC DRUG MONITORING
- The therapeutic alliance: is it necessary or sufficient to engender positive outcomes?
- (2009) Craig A. Macneil et al. ACTA NEUROPSYCHIATRICA
- The evolution of depression and suicidality in first episode psychosis
- (2009) R. Upthegrove et al. ACTA PSYCHIATRICA SCANDINAVICA
- Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
- (2009) Douglas E Faries et al. BMC Psychiatry
- Attitudes of patients and mental health staff to antipsychotic long-acting injections: Systematic review
- (2009) Linda Waddell et al. BRITISH JOURNAL OF PSYCHIATRY
- First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: Systematic review of randomised controlled trials and observational studies
- (2009) Peter M. Haddad et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic long-acting injections: Prescribing practice in the UK
- (2009) Thomas R. E. Barnes et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic Drugs for First-Episode Schizophrenia
- (2009) Kayvon Salimi et al. CNS DRUGS
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- Pharmacotherapy of patients with schizophrenia and substance abuse
- (2009) Thomas Wobrock et al. EXPERT OPINION ON PHARMACOTHERAPY
- Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?
- (2009) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia
- (2009) Jae Seung Chang et al. JOURNAL OF CLINICAL PSYCHIATRY
- High-Dose Olanzapine for Treatment-Resistant Schizophrenia
- (2009) Bryan L. Roth JOURNAL OF CLINICAL PSYCHIATRY
- Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
- (2009) Diana O. Perkins et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation
- (2009) Theodore D. Satterthwaite et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia
- (2009) Lone Baandrup et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
- (2009) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Psychiatrists’ attitude towards and knowledge of clozapine treatment
- (2009) J. Nielsen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
- (2009) Shaun M. Purcell et al. NATURE
- Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
- (2009) Bruce J Kinon et al. NEUROPSYCHOPHARMACOLOGY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients
- (2009) John P. Houston et al. PSYCHIATRY RESEARCH
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Economic impact of early intervention in people at high risk of psychosis
- (2009) L. R. Valmaggia et al. PSYCHOLOGICAL MEDICINE
- Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
- (2009) A. Demjaha et al. PSYCHOLOGICAL MEDICINE
- IQ Trajectory, Cognitive Reserve, and Clinical Outcome Following a First Episode of Psychosis: A 3-Year Longitudinal Study
- (2009) Verity C. Leeson et al. SCHIZOPHRENIA BULLETIN
- Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
- (2009) Hiroyuki Uchida et al. SCHIZOPHRENIA BULLETIN
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
- (2009) R. W. Buchanan et al. SCHIZOPHRENIA BULLETIN
- Influence of antipsychotics on mortality in schizophrenia: Systematic review
- (2009) Stefan Weinmann et al. SCHIZOPHRENIA RESEARCH
- Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders
- (2009) A.B.P. Staring et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia and Violence: Systematic Review and Meta-Analysis
- (2009) Seena Fazel et al. PLOS MEDICINE
- Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia
- (2008) M. Lambert et al. ACTA PSYCHIATRICA SCANDINAVICA
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
- (2008) Rohan Ganguli et al. BMC Medicine
- Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
- (2008) Gunnar Morken et al. BMC Psychiatry
- High-dose and combination antipsychotic prescribing in acute adult wards in the UK: The challenges posed by p.r.n. prescribing
- (2008) Carol Paton et al. BRITISH JOURNAL OF PSYCHIATRY
- Extrapyramidal side-effects of antipsychotics in a randomised trial
- (2008) Del D. Miller et al. BRITISH JOURNAL OF PSYCHIATRY
- Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts
- (2008) Kimford Meador et al. EPILEPSY RESEARCH
- Overview of the findings from the European SOHO study
- (2008) David Suarez et al. Expert Review of Neurotherapeutics
- Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?
- (2008) Leslie Citrome Expert Review of Neurotherapeutics
- Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Heterogeneity of violence in schizophrenia and implications for long-term treatment
- (2008) J. Volavka et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study
- (2008) Sanjiv Kumra et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A New Look at the Neonate's Clinical Presentation After In Utero Exposure to Antidepressants in Late Pregnancy
- (2008) Nina Boucher et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Open-Label Comparison of 2 Switching Strategies to Aripiprazole Treatment in Patients With Schizophrenia
- (2008) Hiroyoshi Takeuchi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Depot and oral antipsychotics: patient preferences and attitudes are not the same thing
- (2008) MX Patel et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Amisulpride Augmentation in Patients with Schizophrenia Partially Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) H.-J. Assion et al. PHARMACOPSYCHIATRY
- Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
- (2008) Borah Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of choice on intrinsic motivation and related outcomes: A meta-analysis of research findings.
- (2008) Erika A. Patall et al. PSYCHOLOGICAL BULLETIN
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
- (2008) C. U. Correll et al. SCHIZOPHRENIA BULLETIN
- Rates of Homicide During the First Episode of Psychosis and After Treatment: A Systematic Review and Meta-analysis
- (2008) O. Nielssen et al. SCHIZOPHRENIA BULLETIN
- Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?
- (2008) C. Barbui et al. SCHIZOPHRENIA BULLETIN
- Psychiatric Comorbidities and Schizophrenia
- (2008) P. F. Buckley et al. SCHIZOPHRENIA BULLETIN
- The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study
- (2008) Marvin S. Swartz et al. SCHIZOPHRENIA RESEARCH
- The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder
- (2008) Matthew J. Byerly et al. SCHIZOPHRENIA RESEARCH
- Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆
- (2008) B KINON et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Does switching to a new antipsychotic improve outcomes?
- (2008) Robert A Rosenheck et al. SCHIZOPHRENIA RESEARCH
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
- (2007) Istvan Bitter et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain
- (2007) Antonio Ciudad et al. EUROPEAN PSYCHIATRY
- Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity
- (2007) Paul A. Nakonezny et al. PSYCHIATRY RESEARCH
- Use of Depot Antipsychotic Medications for Medication Nonadherence in Schizophrenia
- (2007) J. C. West et al. SCHIZOPHRENIA BULLETIN
- Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
- (2007) C. Daniel Mullins et al. SCHIZOPHRENIA RESEARCH
- A large-scale validation study of the Medication Adherence Rating Scale (MARS)
- (2007) Laura Fialko et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started